Literature DB >> 10482569

Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus.

R J Gorelick1, W Fu, T D Gagliardi, W J Bosche, A Rein, L E Henderson, L O Arthur.   

Abstract

Mutagenesis studies have shown that retroviral nucleocapsid (NC) protein Zn(2+) fingers (-Cys-X(2)-Cys-X(4)-His-X(4)-Cys- [CCHC]) perform multiple functions in the virus life cycle. Moloney murine leukemia virus mutants His 34-->Cys (CCCC) and Cys 39-->His (CCHH) were able to package their genomes normally but were replication defective. Thermal dissociation experiments showed that the CCHH mutant was not defective in genomic RNA dimer structure. Primer tRNA placement on the viral genome and the ability of the tRNA to function in reverse transcription initiation in vitro also appear normal. Some "full-length" DNA copies of the viral genome were synthesized in mutant virus-infected cells. The CCCC and CCHH mutants produced these DNA copies at greatly reduced levels. Circle junction fragments, amplified from two-long-terminal-repeat viral DNA (vDNA) by PCR, were cloned and characterized. Remarkably, it was discovered that vDNA isolated from cells infected with mutant virions had a wide variety of abnormalities at the site at which the two ends of the linear precursor had been ligated to form the circle (i.e., the junction between the 5' end of U3 and the 3' end of U5). In some molecules, bases were missing from regions corresponding to the U3 and U5 linear vDNA termini; in others, the viral sequences extended either beyond the U5 sequences into the primer-binding site and 5' leader or beyond the U3 sequences into the polypurine tract into the env coding region. Still other molecules contained nonviral sequences between the linear vDNA termini. Such defective genomes would certainly be unsuitable substrates for integration. Thus, strict conservation of the CCHC structure in NC is required for infection events prior to and possibly including integration.

Entities:  

Mesh:

Year:  1999        PMID: 10482569      PMCID: PMC112836          DOI: 10.1128/JVI.73.10.8185-8195.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses.

Authors:  J L Darlix; M Lapadat-Tapolsky; H de Rocquigny; B P Roques
Journal:  J Mol Biol       Date:  1995-12-08       Impact factor: 5.469

2.  Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.

Authors:  R J Gorelick; D J Chabot; D E Ott; T D Gagliardi; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Formation of stable and functional HIV-1 nucleoprotein complexes in vitro.

Authors:  V Tanchou; C Gabus; V Rogemond; J L Darlix
Journal:  J Mol Biol       Date:  1995-10-06       Impact factor: 5.469

4.  HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.

Authors:  Y X Feng; T D Copeland; L E Henderson; R J Gorelick; W J Bosche; J G Levin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.

Authors:  D E Ott; J Keller; K Sill; A Rein
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.

Authors:  A Engelman; G Englund; J M Orenstein; M A Martin; R Craigie
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements.

Authors:  R Swanstrom; W J DeLorbe; J M Bishop; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome.

Authors:  B Allain; M Lapadat-Tapolsky; C Berlioz; J L Darlix
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  31 in total

1.  The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition.

Authors:  A Akhtar; P B Becker
Journal:  EMBO Rep       Date:  2001-02       Impact factor: 8.807

2.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Jianhui Guo; Tiyun Wu; Bradley F Kane; Donald G Johnson; Louis E Henderson; Robert J Gorelick; Judith G Levin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.

Authors:  R J Gorelick; R E Benveniste; J D Lifson; J L Yovandich; W R Morton; L Kuller; B M Flynn; B A Fisher; J L Rossio; M Piatak; J W Bess; L E Henderson; L O Arthur
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; Edward Arnold; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

7.  Essential domains for ribonucleoprotein complex formation required for retrotransposition of telomere-specific non-long terminal repeat retrotransposon SART1.

Authors:  Takumi Matsumoto; Mitsuhiro Hamada; Mizuko Osanai; Haruhiko Fujiwara
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation.

Authors:  A Cimarelli; J Luban
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 9.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

10.  Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells.

Authors:  Caroline Goujon; Loraine Jarrosson-Wuilleme; Jeanine Bernaud; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.